Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s software/display footer revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now lists Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to study details or page layout.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous v3.4.1. This appears to be a minor metadata update with no substantive changes to the study content or displayed information.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no visible changes to page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.